Esperion Therapeutics Inc (ESPR NASDAQ) stock market data APIs
$2.6715
0.09(3.4%)
as of October 23, 2025
Try our APIs with
free plan!
Esperion Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. Its products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. It has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
Prev. Close
2.6715
Open
2.7615
High
2.769
Low
2.6265
52 wk Range
0.6925-3.94
Market Cap
621 M
Shares Outstanding
232 M
Revenue
268 M
EPS
-0.02
Beta
0.961
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Esperion Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Esperion Therapeutics Inc data using free add-ons & libraries
Get Esperion Therapeutics Inc Fundamental Data
Esperion Therapeutics Inc Fundamental data includes:
- Net Revenue: 268 M
- EBITDA: -35 341 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-05
- EPS/Forecast: -0.14
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Esperion Therapeutics Inc News
New
CREATING POSITIVE IMPACT IN SUSTAINABILITY
Sika AG CREATING POSITIVE IMPACT IN SUSTAINABILITY Sika is advancing its sustainability strategy with the introduction of the Sika® Carbon Compass – an automated platform for calculating Product ...
Market Minute 10-20-25- Shutdown Now Third-Longest Ever
Stocks, gold, silver, and Bitcoin are all rallying in early trading. Crude oil is easing back, while Treasuries and the dollar are flattish. The federal government shutdown has spilled over into anot...
ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up
Esperion Therapeutics ESPR announced that it has nominated ESP-2001, a highly specific allosteric ATP citrate lyase (“ACLY”) inhibitor, as its new preclinical development candidate for the treatme...
Market Minute 10-14-25- Trade Woes Resurface as Q3 Earnings Flood In
Trade headlines are causing more headaches on Wall Street, with stocks giving back ground after a surge on Monday. Gold and silver are flattish after a big recent rally, while crude oil is trading low...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
